MediThinQ's ScopeEye Named 2025 Global Leading Product

MedisyncQ's innovative product 'SCOPEYE', a leader in medical XR·3D visual solutions, has proudly been named a '2025 Next-Generation World-Class Product' by the Ministry of Trade, Industry and Energy (MOTIE) and KOTRA, officially recognizing its technological prowess and potential. This selection proves that SCOPEYE has secured unparalleled technological capabilities in the field of medical AR·3D display technology and a firm competitive edge in the global market. SCOPEYE is an advanced solution equipped with 'Eyes Up' 3D display technology, set to change the paradigm of medical fields, implementing high-definition medical images in real-time right in front of the medical team's eyes. It boasts excellent compatibility with existing video medical devices and offers the convenience of connectivity without separate software installation. Furthermore, it supports medical professionals to focus on procedures in the most comfortable and efficient posture, and satisfies the needs of the medical field with wireless 3D visualization technology, Air Writing-based collaborative education features, and broad compatibility encompassing endoscopic, microscopic, and robotic surgical environments. SCOPEYE also has a solid foothold for global market entry. It has completed all major market certifications including the US, Europe, and Korea, and has successfully concluded over 10,000 demonstrations and clinical tests in numerous medical institutions. Since last year, it has demonstrated its strength by signing exclusive contracts with leading healthcare technology companies in the US and European markets, and in May this year, it firmly established its global standing by successfully entering the vast Chinese market through an exclusive supply contract with Sinopharm, China's largest medical group. Meanwhile, MedisyncQ is participating in 'MEDICA 2025', a global medical device exhibition held this week in Düsseldorf, Germany, actively showcasing innovative solutions such as '3D Digital X-Scope SHIYA 20' along with SCOPEYE, and receiving keen interest from local medical professionals. Lim Seung-jun, CEO of MedisyncQ, stated that this selection reconfirmed SCOPEYE's unparalleled technological capabilities and explosive growth potential in the global market, expressing his aspiration to continue dedicating efforts to developing XR·3D display solutions that solve challenges in medical fields, thereby leading the global healthcare market. Building on SCOPEYE's success, MedisyncQ plans to accelerate the development of next-generation XR-based visualization solutions, including ultra-compact 3D microscopes and 3D digital loupes.